Logistics and low enrollment.

The NanoCOAT study is a multi-center, prospective, non-randomized, feasibility, observational, non-significant risk study. The NanoCOAT study will enroll a minimum of 10 and a maximum of 100 subjects in a potential for a multi-site in order to collect data and analyze physiological and biometric trends due to Covid-19.

Inclusion Criteria:

• Subject has provided informed consent
• Male or female over the age of 18 years
• The patient is currently hospitalized with a primary diagnosis of Covid-19

Exclusion Criteria:

• Subject is unwilling or unable to wear the vest during hospitalization.
• Subjects who are pregnant.
• Subject is intubated or admitted to ICU
• Subject has an implantable cardiac device (i.e pacemaker or internal cardioverter defibrillator)

Subjects of legal age to give informed consent who are currently or recently hospitalized with a primary diagnosis of Covid-19